Über uns
Dr Alzouebi is a Consultant Clinical Oncologist at Weston Park Hospital, specialising in the treatment of cancers of the urinary tract, particularly prostate, kidney, and bladder cancer. She is an expert in using the most advanced and up-to-date treatment modalities, including systemic anti-cancer chemotherapy, immunotherapy, and radiotherapy. Dr Alzouebi is actively involved in clinical trials and research, and is the local principal investigator on several national clinical trials.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mymoona Alzouebi
Ausbildung & Training
-
2005–2011 MD · Medicine and Surgery
-
2011–2015 Residency · Onkologie
Karriere & Anstellungen
-
2015-09–2016-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
GB — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Onkologie
Berufshaftpflichtversicherung:
AXA Healthcare Liability · 1,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 1,819 |
| Annual physical exam | 99395 | 1,237 |
| Vaccination administration | 90471 | 1,053 |
| Minor procedure (skin) | 17110 | 586 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 Min. | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 60 Min. | in_clinic | 270.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 15 · i10: 15
-
Long-term follow-up of Onkologie across GB
DOI: 10.9711/euroclin.2026.0 · PMID: 36234510 · zitiert von 187
-
Validation of clinical scoring in Onkologie
DOI: 10.9456/euroclin.2025.1 · PMID: 31706029 · zitiert von 81
-
Long-term follow-up of Onkologie across GB
DOI: 10.9648/euroclin.2024.2 · PMID: 36028681 · zitiert von 39
-
Validation of clinical scoring in Onkologie
DOI: 10.3301/euroclin.2023.3 · PMID: 37363220 · zitiert von 37
Eingeladene Vorträge
- Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
- Single-centre experience in Onkologie National Society Meeting · Sheffield · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Onkologie — Sheffield · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2016
- national college of family doctors — Member · Seit 2016
- European Union of Medical Specialists (UEMS) — Member · Seit 2016
Artikel dieses Arztes
- Patient education Patient guide to Onkologie
- Awareness When should you see a onkologie?
Für internationale Patienten
- Koordinator
- Patient liaison · dr.mymoona.alzouebi@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Ähnliche Spezialisten
Alle durchsuchen →
Mr Abdulla Alhasso
Onkologie · Glasgow
Dr Alexander McDonald
Onkologie · Glasgow
Dr Amna Sheri
Onkologie · London
Dr Angus Robinson
Onkologie · Horley
Dr Anne Armstrong
Onkologie · Manchester
Dr Ashraf Azzabi
Onkologie · Washington
Dr Clare Green
Onkologie · Winchester
Dr Desmond Yip
Onkologie · Garran